Literature DB >> 29509589

Gaps Along the HIV Care Continuum: Findings Among a Population Seeking Sexual Health Care Services in New York City.

Preeti Pathela1, Kelly Jamison1, Sarah L Braunstein2, Julia A Schillinger1,3, Olga Tymejczyk4,5, Denis Nash4,5.   

Abstract

BACKGROUND: Linkage/relinkage to HIV care for virally unsuppressed people with new sexually transmitted infections is critical for ending the HIV epidemic. We quantified HIV care continuum gaps and viral suppression among HIV-positive patients attending New York City (NYC) sexual health clinics (SHCs).
METHODS: One thousand six hundred forty-nine HIV-positive patients and a 10% sample of 11,954 patients with unknown HIV status on clinic visit date (DOV) were matched against the NYC HIV registry. Using registry diagnosis dates, we categorized matched HIV-positive patients as "new-positives" (newly diagnosed on DOV), "recent-positives (diagnosed ≤90 days before DOV), "prevalent-positives" (diagnosed >90 days before DOV), and "unknown-positives" (previously diagnosed but status unknown to clinic on DOV). We assessed HIV care continuum outcomes before and after DOV for new-positives, prevalent-positives, and unknown-positives using registry laboratory data.
RESULTS: In addition to 1626 known HIV-positive patients, 5% of the unknown sample (63/1196) matched to the registry, signifying that approximately 630 additional HIV-positive patients attended SHCs. Of new-positives, 65% were linked to care after DOV. Of prevalent-positives, 66% were in care on DOV; 43% of the out-of-care patients were relinked after DOV. Of unknown-positives, 40% were in care on DOV; 21% of the out-of-care patients relinked after DOV. Viral suppression was achieved by 88% of in-care unknown-positives, 76% in-care prevalent-positives, 50% new-positives, 42% out-of-care prevalent-positives, and 16% out-of-care unknown-positives.
CONCLUSIONS: Many HIV-positive people, including those with uncontrolled HIV infection, attend SHCs and potentially contribute to HIV spread. However, HIV status often is not known to staff, resulting in missed linkage/relinkage to care opportunities. Better outcomes could be facilitated by real-time ascertainment of HIV status and HIV care status.

Entities:  

Mesh:

Year:  2018        PMID: 29509589      PMCID: PMC5997517          DOI: 10.1097/QAI.0000000000001674

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  15 in total

1.  Impact of rectal gonorrhoea and chlamydia on HIV viral load in the rectum: potential significance for onward transmission.

Authors:  Olubanke Davies; Sinead Costelloe; Gemma Cross; Tracy Dew; Siobhan O'Shea; John White; Julie Fox
Journal:  Int J STD AIDS       Date:  2017-01-12       Impact factor: 1.359

2.  Universal voluntary testing and treatment for prevention of HIV transmission.

Authors:  Carl W Dieffenbach; Anthony S Fauci
Journal:  JAMA       Date:  2009-06-10       Impact factor: 56.272

Review 3.  Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases.

Authors:  J N Wasserheit
Journal:  Sex Transm Dis       Date:  1992 Mar-Apr       Impact factor: 2.830

4.  HIV incidence among men with and those without sexually transmitted rectal infections: estimates from matching against an HIV case registry.

Authors:  Preeti Pathela; Sarah L Braunstein; Susan Blank; Julia A Schillinger
Journal:  Clin Infect Dis       Date:  2013-06-25       Impact factor: 9.079

5.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

Review 6.  From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection.

Authors:  D T Fleming; J N Wasserheit
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

7.  HIV status and viral loads among men testing positive for rectal gonorrhoea and chlamydia, Maricopa County, Arizona, USA, 2011-2013.

Authors:  M M Taylor; D R Newman; J Gonzalez; J Skinner; R Khurana; T Mickey
Journal:  HIV Med       Date:  2014-09-17       Impact factor: 3.180

8.  Time above 1500 copies: a viral load measure for assessing transmission risk of HIV-positive patients in care.

Authors:  Gary Marks; Lytt I Gardner; Charles E Rose; Anne Zinski; Richard D Moore; Susan Holman; Allan E Rodriguez; Meg Sullivan; Thomas P Giordano
Journal:  AIDS       Date:  2015-05-15       Impact factor: 4.177

9.  Improved HIV-related outcomes associated with implementation of a novel public health information exchange.

Authors:  Manya Magnus; Jane Herwehe; DeAnn Gruber; Wayne Wilbright; Elizabeth Shepard; Amir Abrams; Joe Foxhood; Luis Smith; Ke Xiao; Kathryn DeYoung; Michael Kaiser
Journal:  Int J Med Inform       Date:  2012-08-09       Impact factor: 4.046

10.  Implementation of an innovative, integrated electronic medical record (EMR) and public health information exchange for HIV/AIDS.

Authors:  Jane Herwehe; Wayne Wilbright; Amir Abrams; Susan Bergson; Joseph Foxhood; Michael Kaiser; Luis Smith; Ke Xiao; Amy Zapata; Manya Magnus
Journal:  J Am Med Inform Assoc       Date:  2011-10-28       Impact factor: 4.497

View more
  2 in total

1.  HIV Care and Viral Load Suppression After Sexual Health Clinic Visits by Out-of-Care HIV-Positive Persons.

Authors:  Olga Tymejczyk; Kelly Jamison; Preeti Pathela; Sarah Braunstein; Julia A Schillinger; Denis Nash
Journal:  AIDS Patient Care STDS       Date:  2018-10       Impact factor: 5.078

2.  The Facility-Level HIV Treatment Cascade: Using a Population Health Tool in Health Care Facilities to End the Epidemic in New York State.

Authors:  Daniel J Ikeda; Leah Hollander; Susan Weigl; Steven V Sawicki; Daniel R Belanger; Nova Y West; Nanette Brey Magnani; Christopher G Wells; Peter Gordon; Johanne Morne; Bruce D Agins
Journal:  Open Forum Infect Dis       Date:  2018-10-26       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.